Intellectual Property

  • June 10, 2025

    Key Insights On Looming Fair Use Rulings In AI Cases

    Two California federal judges have indicated they are inclined to find that using copyrighted material to train artificial intelligence systems is transformative, which usually means that copying a work is fair, but that may not let Meta Platforms and Anthropic off the hook in separate lawsuits.

  • June 10, 2025

    Ill. Judge Questions Standing In Biogen Antitrust Suit

    An Illinois federal judge seemed skeptical Tuesday that health benefit plans accusing Biogen of impairing competition for its multiple sclerosis drug, Tecfidera, have standing to bring their lawsuit under decades-old precedent allowing only direct purchasers to recoup damages.

  • June 10, 2025

    Stewart Blocks PTAB From Eyeing Container Assembly IP

    The U.S. Patent and Trademark Office's acting director has reversed Patent Trial and Appeal Board decisions that had initiated reviews of patents covering container assembly products, saying the board failed to sufficiently account for U.S. International Trade Commission proceedings over the same patents.

  • June 10, 2025

    11th Circ. Revives Suit Over 'Summer Waves' TM

    The Eleventh Circuit on Tuesday revived a trademark lawsuit that the entity behind a Georgia waterpark launched against an inflatable pool maker over its purported use of the phrase "summer waves," finding a lower court has jurisdiction to hear the case.

  • June 10, 2025

    Lawmakers Float NIL Bills Following NCAA Deal

    Members of Congress introduced a pair of bills Tuesday looking to establish national standards for how college athletes monetize their name, image and likeness in the wake of the landmark NCAA class action settlement last week.

  • June 10, 2025

    Paramount Says 'Top Gun' Authorship Claim Is 'A Delusion'

    Paramount Pictures Corp. urged a New York federal judge Monday to dismiss a lawsuit brought by the cousin of a "Top Gun: Maverick" screenwriter who claims he is a joint author of the film's script, saying his complaint is "a delusion."

  • June 10, 2025

    Spokesman Sues Motel 6 Over Unauthorized Use Of His Voice

    Tom Bodett, a radio personality and voice actor known for Motel 6's radio and television ads for nearly 40 years, has sued the hospitality chain for allegedly using his name and voice without consent after he ended an agreement.

  • June 10, 2025

    4th Circ. Backs Contract Verdict Against Turkish Weapons Co.

    The Fourth Circuit on Tuesday rejected a Turkish military supplier's appeal in a case where a Virginia federal jury found that it owed $720,000 for breaching a 2019 agreement between it and a U.S. importer.

  • June 10, 2025

    OpenAI Hit With Trademark Suit Over IO Co. Name

    Technology company IYO Inc. has accused OpenAI and its CEO Sam Altman of knowingly infringing its trademark when the company acquired competitor IO Products Inc. last month.

  • June 10, 2025

    Ex-GC Accused Of Stealing IP Amid Ownership Stake Dispute

    E-commerce company Storehouse In A Box sued its former general counsel and chief operating officer in Michigan federal court Monday, alleging he misappropriated trade secrets and confidential information, while also engaging in outside ventures that conflicted with his duties, after a dispute arose over his ownership claim in the business.

  • June 10, 2025

    Photographer Says Marlon Wayans Took Pot Pic

    Marlon Wayans, star of such films as "White Chicks" and "Scary Movie," was hit with a copyright infringement lawsuit on Tuesday by a photographer who claims he used her image of a Ziploc bag filled with marijuana on his Facebook account without permission.

  • June 10, 2025

    Judge Warns Attys Over Candor In Grubhub-Kroger TM Row

    An Illinois federal judge on Monday admonished defense counsel in ongoing trademark litigation between Grubhub Inc. and The Kroger Co. after finding discrepancies in the Kroger attorney's representations of information Grubhub provided in a discovery response, reminding all lawyers involved of their duty of candor and adherence to professional conduct rules.

  • June 10, 2025

    Merck Gets PTAB To Nix Johns Hopkins Cancer Drug Patent

    Merck & Co. Inc. subsidiary Merck Sharp & Dohme LLC has notched a win at the Patent Trial and Appeal Board in its disagreement with Johns Hopkins University over a cancer research partnership, persuading a panel to invalidate claims in a university-owned patent relating to a colorectal cancer treatment.

  • June 10, 2025

    Neurocrine Loses Suit Challenging Hormone Treatment Patent

    Neurocrine Biosciences has lost its attempt in Delaware federal court to invalidate a patent owned by biotechnology company Spruce Biosciences Inc. relating to the treatment of a hormonal disorder, after a federal judge tossed the lawsuit.

  • June 09, 2025

    Squires Dodges Trump Questions, Emphasizes AI For Backlog

    The Trump administration's nominee for U.S. Patent and Trademark Office director avoided answering whether Joe Biden won the 2020 election, how to describe defendants in the Jan. 6, 2021, attack on the U.S. Capitol and whether he would follow an illegal directive from the president, along with addressing concerns about USPTO resources and artificial intelligence in post-hearing responses to senators.

  • June 09, 2025

    Judge To Limit Experts in Biogen, Genentech Drug Royalty Trial

    A California federal judge Monday laid out the ground rules for an upcoming high-stakes jury trial between Biogen and Roche Holding AG subsidiary Genentech over patent royalties on multiple sclerosis drug sales, giving each side nine hours to argue their case and saying she plans to limit expert testimony.

  • June 09, 2025

    Acadia Win On Parkinson's Drug Patent Upheld By Fed. Circ.

    The Federal Circuit on Monday upheld the validity of an Acadia Pharmaceuticals Parkinson's disease drug patent, saying the result was compelled by double-patenting precedent the court set last year, but generics maker MSN Laboratories has suggested it may seek en banc review.

  • June 09, 2025

    Patent Suit Against Sirius XM Gets 2nd Fed. Circ. Reprieve

    The Federal Circuit on Monday revived a patent case against satellite radio company Sirius XM for a second time, reversing a lower court's ruling that a German research foundation's five-year delay in alleging infringement meant it was prohibited from pursuing the case.

  • June 09, 2025

    Ex-Exec Stole Data And Solicited Clients For Rival, Suit Says

    Georgia-based software firm Trinoor LLC has filed a lawsuit against a former vice president the company alleges deleted and stole "vast amounts" of internal data before jumping ship to join a competitor earlier this year.

  • June 09, 2025

    Judge Cites Golf Films In Axing Tiger Woods' League TM Suit

    A Delaware federal judge on Monday dismissed a trademark suit filed by a company started by golfers Tiger Woods and Rory McIlroy against LA Golf Partners LLC, all while citing golf films "Caddyshack," "Tin Cup" and "Happy Gilmore."

  • June 09, 2025

    Purple Innovation Can't Get Fees In Mattress TM Feud

    A South Carolina federal judge has denied a motion for attorney fees filed by Purple Innovation Inc. and Purple Innovation LLC in a trademark dispute with American Serleep, finding that the case didn't meet the Lanham Act's "exceptional" standard for awarding such fees.

  • June 09, 2025

    Micron Spread 'Xenophobic Lies,' Rival's False Ad Suit Says

    Chinese chipmaker Yangtze Memory Technologies Corp. has slapped Micron Technology and lobbying firm DCI Group AZ LLC with a false advertising lawsuit in D.C. federal court claiming the U.S. rival and DCI Group spread "xenophobic lies" that its chips can be used to spy on Americans at the Chinese government's behest.

  • June 09, 2025

    Edwards Can't Get Fed. Circ. To Overrule PTAB Amendments

    The Patent Trial and Appeal Board rightly held that amended claims of a Cardiovalve Ltd. heart valve implant aren't invalid, the Federal Circuit affirmed Monday.

  • June 09, 2025

    Fitch Even's Ex-IP Client Wants Firm's Patent Suit Tossed

    Prenatal-Hope Inc. and its chief executive officer are asking an Illinois federal judge to dismiss a suit in which law firm Fitch Even Tabin & Flannery LLP seeks a declaration that the CEO isn't the inventor behind a prenatal test patent.

  • June 09, 2025

    Sheppard Mullin Adds Perkins Coie IP Trio In DC, Chicago

    Three Perkins Coie LLP intellectual property partners with deep experience representing clients in the pharmaceutical, biotechnology and related industries have jumped to Sheppard Mullin Richter & Hampton LLP.

Expert Analysis

  • What Public View Of CEO's Killing Means For Corporate Trials

    Author Photo

    Given the proliferation of anti-corporate sentiments following recent charges against Luigi Mangione in connection with the killing of UnitedHealthcare's CEO, attorneys who represent corporate clients and executives will need to adapt their trial strategy to account for juror anger, says Clint Townson at Townson Litigation Consulting.

  • Private-Bidding Compliance Lessons From Siemens Plea Deal

    Author Photo

    Siemens Energy’s recent wire fraud conspiracy guilty plea shows that U.S. prosecutors are willing and able to police the private, domestic bidding market to protect the integrity of the competitive marketplace, and companies will need a robust compliance program to mitigate these risks, say attorneys at Foley Hoag.

  • Lessons From The Pharma Industry On Patent Cliffs

    Author Photo

    In the next five years, patents for drugs that have generated billions in global sales are set to expire, and companies that view this imminent patent cliff as an opportunity for strategic renewal rather than a challenge will be best positioned to maintain market leadership, says Keegan Caldwell at Caldwell Law.

  • FTC Report On AI Sector Illuminates Future Enforcement

    Author Photo

    The Federal Trade Commission's report on cloud service providers and their partnerships with developers of artificial intelligence's large language models suggests that the agency will move to rein in Big Tech with antitrust enforcement to protect startups, say attorneys at Squire Patton.

  • Artfully Conceding Liability Can Offer Defendants 3 Benefits

    Author Photo

    In the rare case that a company makes the strategic decision to admit liability, it’s important to do so clearly and consistently in order to benefit from the various forms of armor that come from an honest acknowledgment, says Ken Broda-Bahm at Persuasion Strategies.

  • Mentorship Resolutions For The New Year

    Author Photo

    Attorneys tend to focus on personal achievements or career milestones when they set yearly goals, but one important area often gets overlooked in this process — mentoring relationships, which are some of the most effective tools for professional growth, say Kelly Galligan at Rutan & Tucker and Andra Greene at Phillips ADR.

  • What Nearshoring Growth In Americas Means For Patents

    Author Photo

    With the new U.S. administration potentially focused on implementing draconian trade restrictions, nearshoring in the Americas is expected to grow, and patent prosecution attorneys will be kept on their toes as the patent landscape from country to country continues to evolve, says Ernest Huang at Procopio.

  • Series

    Coaching Little League Makes Me A Better Lawyer

    Author Photo

    While coaching poorly played Little League Baseball early in the morning doesn't sound like a good time, I love it — and the experience has taught me valuable lessons about imperfection, compassion and acceptance that have helped me grow as a person and as a lawyer, says Alex Barnett at DiCello Levitt.

  • Influencer IP Case Risks Judges Becoming Arbiters Of 'Vibes'

    Author Photo

    The case of Gifford v. Sheil, pending in Texas federal court, involves an influencer alleging that distinctive social media aesthetics constitute protectable property, and reflects a troubling trend: the overreach of intellectual property law in areas better left for creative freedom, say attorneys at Holland & Knight.

  • 5 Litigation Funding Trends To Note In 2025

    Author Photo

    Lawyers and their clients must be prepared to navigate an evolving litigation funding market in 2025, made more complicated by a new administration and the increasing overall cost of litigation, says Jeffery Lula at GLS Capital.

  • A Look At FDA's Plans To Establish New OTC Drug Category

    Author Photo

    The U.S. Food and Drug Administration's recently finalized rule, creating a new over-the-counter pathway for drugs when patients satisfy certain conditions, may be useful for off-patent drugs with established safety records, though switching to OTC comes with additional costs and considerations, say attorneys at Skadden.

  • The Fed. Circ. In 2024: 5 Major Rulings To Know

    Author Photo

    In 2024, the Federal Circuit provided a number of important clarifications to distinct areas of patent law – including design patent obviousness, expert testimony admissions and patent term adjustments – all of which are poised to have an influence going forward, say attorneys at Knobbe Martens.

  • Rethinking Litigation Risk And What It Really Means To Win

    Author Photo

    Attorneys have a tendency to overestimate litigation risk before summary judgment and underestimate risk after it, but an eight-stage litigation framework can clarify risk at different points and help litigators reassess what true success looks like in any particular case, says Joshua Libling at Arcadia Finance.

  • Patent Ruling Sheds Light On Printed Matter Doctrine

    Author Photo

    Patent attorneys should pay attention to the claim language highlighted in Ioengine v. Ingenico, where the Federal Circuit held that program code was not printed matter, but essentially instructions or content, and therefore not subject to the printed matter doctrine for patent challenges, says Irah Donner at Manatt.

  • How DOGE's Bite Can Live Up To Its Bark

    Author Photo

    All signs suggest that the Department of Government Efficiency will be an important part of the new Trump administration, with ample tools at its disposal to effectuate change, particularly with an attentive Republican-controlled Congress, say attorneys at K&L Gates.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.